PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...

A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...

French drama over sovereign paracetamol is really about a deeper ailment: underinvestment.

Sanofi said its Opella business has been valued at around 16 billion euros (USD17.38 billion), or 14 times EBITDA in 2024 ...

High-dose flu vaccinations resulted in a 23% reduction in hospitalizations among people aged 65 years or older, according to ...

Sanofi and Sudair Pharma Company (SPC) have joined forces to establish a state-of ... Our team, across some 100 countries, is ...

French drugmaker Sanofi's confirmation that it will sell a controlling stake in its consumer health unit to a US investment ...

Sanofi, which is joining a growing number of drugmakers shedding consumer related businesses, said Opella had been valued at ...

French drugmaker Sanofi’s confirmation yesterday that it plans to sell a controlling stake in its over-the-counter unit to a ...

Under the trilateral deal signed by Sanofi, CD&R and the government, Opella will have to pay a €40 million penalty if it ...

Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...